The 2021 Pershing Square Sohn Prize for Young Investigators in Cancer Research has been awarded to Xuebing Wu, PhD, for his innovative approaches to cancer research. The Pershing Square Sohn Prize is an annual award that provides early career scientists the freedom to take risks and pursue bold research at a stage when traditional funding is lacking. At Columbia University Irving Medical Center, Dr. Wu shares the designation with Christine Iok In Chio, PhD, whose work focuses on the biological mechanisms that drive pancreatic ductal adenocarcinoma.

With the support from the Pershing Foundation, Dr. Wu and his lab aim to develop a technology for mutation-specific elimination of tumor cells, by integrating a highly programmable CRISPR “gene-editing” system with advanced machine learning algorithms. 

Read the full article in the HICCC Newsroom.